Cardialen
is a Minnesota-based medical device company that develops implantable cardioversion and defibrillation products for the treatment of atrial fibrillation... Read moreCardialen
is a Minnesota-based medical device company that develops implantable cardioversion and defibrillation products for the treatment of atrial fibrillation... Read more
News
Dec 14, 2022
socalTECH
Cardialen: Maxwell Biomedical Buys Cardialen
Dec 16, 2021
Medical Product Outsourcing
Cardialen: Cardialen Awarded $3 Million Federal Grant
Nov 17, 2021
Business Wire
Press Release: Cardialen : Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment
Sep 16, 2021
BioSpace
Cardialen: Cardialen Awarded $3 Million Federal Grant to Advance Therapy Designed to Treat Atrial Fibrillation for Improved Heart Failure Outcomes
Jun 25, 2021
SEC
Cardialen: Cardialen received $4.4M in Debt Funding
Apr 13, 2021
Business Wire
Press Release: Cardialen : Cardialen Announces Positive Results from Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation
Jan 19, 2021
BioSpace
Cardialen: Cardialen Awarded $2.8 Million Federal Grant to Advance Therapy Designed to Treat Dangerous Heart Rhythms
Oct 10, 2018
StartTribune
Cardialen: Minneapolis startup Cardialen raises $17 million in venture capital
Oct 10, 2018
The Business Journals: Minneapolis/St. Paul
Cardialen: Med-tech startup Cardialen to ramp up hiring after raising $17M
Jul 27, 2018
www.sec.gov
Cardialen: Cardialen raises funding
Cardialen Competitors
1
2
3
4
5
6
7
8
9
10